Andrew Weil

Insider Reports History

Identity 1 fact
Location
Petach Tikva, Israel
SEC filing record 1 fact
SEC signature
/s/ Dov Bergwerk as attorney in fact for Andrew Weil
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Andrew Weil:

Form 4 holding Chief Accounting Officer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Security class
Restricted Share Units
Shares / value
29,673
Estimated value
Report date
02 Nov 2021
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Andrew Weil

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .